Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 Earnings

Conmed reported Q3 2026 revenue of $335.56 million, down 0.7% year-over-year, slightly missing consensus estimates. EPS of $1.04 beat expectations of $1.00. The company showed mixed performance across segments, with international revenue up 13.2% but domestic revenue declining 11%. The stock has a Zacks Rank #3 (Hold) rating.